Bacteriostatic and bactericidal activity of levofloxacin against clinical isolates from cystic fibrosis patients

被引：0
|
作者：
G. Golini
F. Favari
F. Marchetti
R. Fontana
机构：
[1] University of Verona,Department of Pathology, Microbiology Section
[2] Ospedale Civile Maggiore,Clinical Microbiology Laboratories
[3] GlaxoSmithKline Spa,Medical Department, Antibacterials Division
来源：
European Journal of Clinical Microbiology and Infectious Diseases | 2004年 / 23卷
关键词：
Cystic Fibrosis; Fluoroquinolones; Levofloxacin; Ceftazidime; Tobramycin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：798 / 800
页数：2
相关论文
共 50 条
  • [41] A demonstration of the susceptibility of clinical isolates obtained from cystic fibrosis patients to manuka honey
    Rowena Jenkins
    Mandy Wootton
    Robin Howe
    Rose Cooper
    Archives of Microbiology, 2015, 197 : 597 - 601
  • [42] Clinical and microbiological features of Inquilinus sp isolates from five patients with cystic fibrosis
    Chiron, R
    Marchandin, H
    Counil, F
    Jumas-Bilak, E
    Freydière, AM
    Bellon, G
    Husson, MO
    Turck, D
    Brémont, F
    Chabanon, G
    Segonds, C
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (08) : 3938 - 3943
  • [43] Bactericidal and bacteriostatic activity of gemifloxacin against Acinetobacter spp. in vitro
    Higgins, PG
    Coleman, K
    Amyes, SGB
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 : 71 - 77
  • [44] Rifampicin potentiation of aminoglycoside activity against cystic fibrosis isolates of Pseudomonas aeruginosa
    Mikalauskas, Alaya
    Parkins, Michael D.
    Poole, Keith
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2017, 72 (12) : 3349 - 3352
  • [45] The efficacy of biosynthesized silver nanoparticles against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Al-Momani, Hafez
    Almasri, Muna
    Al Balawi, Dua'A.
    Hamed, Saja
    Albiss, Borhan Aldeen
    Aldabaibeh, Nour
    Ibrahim, Lugain
    Albalawi, Hadeel
    Al Haj Mahmoud, Sameer
    Khasawneh, Ashraf I.
    Kilani, Muna
    Aldhafeeri, Muneef
    Bani-Hani, Muayyad
    Wilcox, Matthew
    Pearson, Jeffrey
    Ward, Christopher
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [46] The efficacy of biosynthesized silver nanoparticles against Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Hafez Al-Momani
    Muna Almasri
    Dua’A. Al Balawi
    Saja Hamed
    Borhan Aldeen Albiss
    Nour Aldabaibeh
    Lugain Ibrahim
    Hadeel Albalawi
    Sameer Al Haj Mahmoud
    Ashraf I. Khasawneh
    Muna Kilani
    Muneef Aldhafeeri
    Muayyad Bani-Hani
    Matthew Wilcox
    Jeffrey Pearson
    Christopher Ward
    Scientific Reports, 13
  • [47] SYNERGY OF CIPROFLOXACIN WITH FOSFOMYCIN INVITRO AGAINST PSEUDOMONAS ISOLATES FROM PATIENTS WITH CYSTIC-FIBROSIS
    FIGUEREDO, VM
    NEU, HC
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (01) : 41 - 50
  • [48] In vitro bactericidal activity of antibiotic combinations against clinical isolates of mycobacterium chelonae
    Cremades, R.
    Santos, A.
    Rodriguez, J. C.
    Garcia-Pachon, E.
    Ruiz, M.
    Royo, G.
    JOURNAL OF CHEMOTHERAPY, 2008, 20 (01) : 43 - 47
  • [49] Assessing the Antimicrobial Activity of a Synthetic Lipopeptide Against Clinical Cystic Fibrosis Respiratory S. aureus Isolates
    Davies, G.
    Payne, J.
    Laverty, G.
    Gilmore, B. F.
    Tunney, M. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2015, 184 : S538 - S538
  • [50] Effect of oxygen limitation on the in vitro activity of levofloxacin and other antibiotics administered by the aerosol route against Pseudomonas aeruginosa from cystic fibrosis patients
    King, Paula
    Citron, Diane M.
    Griffith, David C.
    Lomovskaya, Olga
    Dudley, Michael N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2010, 66 (02) : 181 - 186
12345